HERBERT Y MELTZER
This article, which was not indicated as written by David Healy, appears to provide a summary of the point of view espoused by Healy in his recent books, The Antidepressant Era and The Creation o/Psychopharmacology. Harvard University Press, Cambridge, Mass. I have written a review of the latter and some of the key ideas in the former in Science (Meltzer, 2002) which I refer the interested reader to for my reasons believing that Healy, a skilled polemiscist who is often loose with facts, must be read with great caution because of the innumerable inaccuracies and selective facts he choses to describe the role of industry, academia and government in the development and marketing of the current generation of psychotropic drugs.
This condensed version of his general point of view, while faithful to the gist of his argument, lacks the polish of his book. I find nothing in it that makes me want to add to my previously published commentary and critique. Statements like the comment that the pharmaceutical industry is "apparendy able to mould academic debate at will and to market psj'chiatric disorders more effectively than they can make new therapeutic agents" yet they are the only source of new therapeutic agents used throughout the world (with considerable improvement in patient outcomes compared to the drugs which Healy advocates, e.g. cyproheptadine for depression and methylene blue for schizophrenia), are self-contradictory.
The final remarks in my review in Science, which refer to the suggestions included in this article that psychotropic drugs be made available without prescription may be worth quoting here.
"The last chapter [of Healy, 2002] is the most original and most challenging part of Healy's book. Healy advances his belief that disorders like schizophrenia and manicdepressive illness will largely disappear as targets for drug development and the clinical activity of psychiatrists, based on possible advances in diagnosis and treatment, to be replaced by personality disorders or other limitations in the human character and intellectual capacity. Should these efforts be successful, he believes that people should be allowed to purchase these drugs without medical supervision. "Any future Rousseau should be able to try the interventions of twenty-first-century psychiatry in a setting that will enable him to decide freely whether they have anything to offer him (Healy 2002, p389) ." [From Meltzer, 2002] It is certainly possible that such Panglossian nostrums could be developed by a massive combined effort of industry, academia, and government. The use of such "life style drugs" as Healy calls them, if they become available, will present a great challenge to society. The abuse of alcohol or tobacco, certainly abetted by the spirits industry's marketing, apparently does not make Healy concerned about what could happen if such drugs became available without some form of control, medical or otherwise. Even acknowledging the harm sometimes done by clinicians who do not use psychotropic drugs well, I find such deregulation an extremely naive and dangerous proposal, one which stems from Healy's fascination with the Enlightenment and Romanticism, rather than a clear vision of what would happen in our culture, with its predilection for mind altering drugs and history of abuse of alcohol. "Caveat emptor" applies to those who would alter mental states and readers of this challenging book alike."
